CLINICAL_TRIALS
withdrawal
· 2017-10-17
Clinical Trial Update: Prostate Artery Embolization for the Treatment of Benign Prostatic Hyperplasia [NA]
Summary
A clinical trial evaluating Prostate Artery Embolization for benign prostatic hyperplasia (NCT03179228) has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: John D Louie | Conditions: Prostatic Hyperplasia | NA | Status: WITHDRAWN